Putnam Announces Dividend Rates for Open-End Funds
Tweet
Share
E-mailBOSTON--(BUSINESS WIRE)-- The Trustees of The Putnam Funds declare the following distributions today.
|
RECORD |
PAYMENT |
|||||
|
FUND NAME AND DISTRIBUTIONS |
DATE |
DATE |
||||
|
George Putnam Balanced Fund – Class B Shares (PGEBX) |
||||||
| $0.0220 per share investment income | 2/26/18 | 2/28/18 | ||||
|
George Putnam Balanced Fund – Class C Shares (PGPCX) |
||||||
| $0.0240 per share investment income | 2/26/18 | 2/28/18 | ||||
|
George Putnam Balanced Fund – Class M Shares (PGEMX) |
||||||
| $0.0350 per share investment income | 2/26/18 | 2/28/18 | ||||
|
George Putnam Balanced Fund – Class R Shares (PGPRX) |
||||||
| $0.0480 per share investment income | 2/26/18 | 2/28/18 | ||||
|
George Putnam Balanced Fund – Class Y Shares (PGEYX) |
||||||
| $0.0710 per share investment income | 2/26/18 | 2/28/18 | ||||
|
George Putnam Balanced Fund – Class R5 Shares (PGELX) |
||||||
| $0.0720 per share investment income | 2/26/18 | 2/28/18 | ||||
|
George Putnam Balanced Fund – Class R6 Shares (PGEJX) |
||||||
| $0.0770 per share investment income | 2/26/18 | 2/28/18 | ||||
|
Putnam Retirement Income Fund Lifestyle 1- Class M Shares (PRMMX) |
||||||
| $0.0020 per share investment income | 2/26/18 | 2/28/18 | ||||
|
Putnam Retirement Income Fund Lifestyle 1- Class R Shares (PRMKX) |
||||||
| $0.0040 per share investment income | 2/26/18 | 2/28/18 | ||||
|
Putnam Retirement Income Fund Lifestyle 1– Class Y Shares (PRMYX) |
||||||
| $0.0100 per share investment income | 2/26/18 | 2/28/18 | ||||
|
Putnam Retirement Income Fund Lifestyle 1– Class R6 Shares (PREWX) |
||||||
| $0.0110 per share investment income | 2/26/18 | 2/28/18 | ||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20180226006412/en/
PUTNAM SHAREHOLDERS CONTACT:
1-800-225-1581
Source: The Putnam Funds
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blank Label Team Opens Search for a Single Global Brand Partner
- Akiram Therapeutics and ITM Sign Lutetium-177 Supply Agreement to Support Development of AKIR001 for the Treatment of Solid Tumors
- Odysight.ai Inc. Announces Pricing of $11 million Public Offering of Common Stock
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Putnam Investments, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
